A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement
Condition:   Post Operative Pain Interventions:   Drug: F14;   Drug: 0.25 % Bupivacaine HCl;   Drug: Acetaminophen;   Drug: Methocarbamol Sponsors:   Arthritis Innovation Corporation;   Allucent Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2022 Category: Research Source Type: clinical trials

Methocarbamol in Ventral and Inguinal HR
Conditions:   Ventral Hernia;   Inguinal Hernia Interventions:   Drug: Methocarbamol;   Drug: Standard Opioid;   Drug: Standard opioid plus methocarbamol Sponsor:   Prisma Health-Upstate Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials